5Zarychanski R,Abou-Setta AM,Turgeon AF,et al.Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation:a systematic review and meta-analysis[J].JAMA,2013,309(7):1 229.
6Haase N,Perner A,Hennings LI,et al.Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis:systematic review with meta-analysis and trial sequential analysis[J].BMJ,2013(15):346.
7Perner A,Haase N,Guttormsen AB,et al.Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis[J].N Engl J Med,2012,367(2):124.
8FDA.Hydroxyethyl starch solutions:FDA safety communication-boxed warning on increased mortality and severe renal injury and risk of bleeding[EB/OL].[2013-06-24].http://www.fda.gov/Safety/MedW atch/Safety Information/Safety Alertsfor Human Medical Products/ucm358349.html.
